deca durabolin dosage

Radiopaque agent for use in children and adults, for performing kardioangiografii, arteriography, urography, venography and contrast enhanced computed tomography (CT); lumbar, thoracic and cervical myelography, CT cisternography after subarachnoid administration; arthrography, endoscopic retrograde pancreato (ERPT), endoscopic retrograde cholangiopancreatography (ERCP), salpingography, sialography and studies of the gastrointestinal tract.

Contraindications:

Hypersensitivity to the drug.
Severe hyperthyroidism.
Local or systemic infections, pregnancy.
Epilepsy and cerebral infection for subarachnoid administration.
Immediate deca durabolin dosage  repeated intrathecal drug in poorly performed myelography.
If there is a history of allergies, bronchospasm or other adverse reactions should be careful when applying yodsoderzhashih contrast agents. In these cases, you should consider the introduction of glucocorticosteroids or blockers of H 1 histamine receptors. Caution must be exercised in the investigation of patients with decompensated diseases of the cardiovascular system and pulmonary hypertensiondue to the risk of cardiac arrhythmias or worsening of hemodynamic instability. Also, care should be taken in the study of patients with bronchial asthma, hay fever, multiple myeloma, food allergies, liver failure, dehydration, multiple sclerosis, sickle cell disease, thromboangiitis obliterans (Buerger’s disease), acute thrombophlebitis, severe atherosclerosis, advanced age, during the lactation.
For lumbar punctures – local or systemic infection.
Patients with acute cerebral disorders, brain tumors or epilepsy prone to develop seizures and require special attention. Increased risk of seizures and neurological reactions in patients with alcoholism and drug abuse.
In order to prevent the development of acute renal failure associated with the administration of contrast medium, requires special care when examining patients with pre- existing renal impairment and diabetes, which are at risk. The same applies to the examination of patients with paraproteinemia (multiple myeloma and Waldenstrom’s macroglobulinemia). The introduction of iodinated contrast media may aggravate the symptoms of myasthenia gravis.
In carrying out invasive research and interventions in patients with pheochromocytoma is necessary prophylactic use of alpha-blockers for the prevention deca durabolin dosage  of hypertensive crisis. It should be particularly careful when examining patients with mild hyperthyroidism, particularly in patients with multinodular goiter. You should be aware of the opportunities for development in connection with the introduction of contrast agents transient thyrotoxicosis in preterm infants.

Pregnancy and lactation:
Omnipak should not be used in pregnant women except in cases where the benefit of its use outweighs the risk of such a study and a physician appointed by necessity.
Contrast agents to a small extent excreted into breast milk and minimally absorbed in the intestine. Therefore, the probability of harm to the baby through breast-feeding is unlikely. Nevertheless, it is advisable to refrain from breastfeeding for 24 hours after administration of Omnipaque.

 

Dosage and administration:

The drug is intended for intra-arterial, vnutrivenoznogo, intrathecal, intracavitary administration, oral administration and rectal administration. Like all formulations for parenteral administration Omnipaque before use should be inspected visually for the absence of insoluble particles, discoloration, and package integrity disorders.
The drug must be typed into the syringe immediately prior to use. Vials are intended for single use only; Unused drug residues shall be destroyed.
With the introduction of the drug the patient should be in a horizontal position. Within 30 minutes after the procedure is carried out medical supervision of the patient, because Most adverse reactions occur during this period. Intrathecal administration: After performing myelography the patient should be at rest for at least 1 hour, lying with raised by 20 ° headboard. If you suspect a low threshold for seizures is necessary to monitor the surveyed for 6 hours. On ambulatory patients should avoid slopes. Dosage depends on the type of study, age and weight of the patient, as well as the hemodynamic status, general health, as well as applied methods and techniques of doing research. The same iodine concentration usually used, and injection volumes, as with other modern iodinated contrast media. Radiopaque agent for use in children and adults, for performing kardioangiografii, arteriography, urography, venography and contrast enhanced computed tomography (CT); lumbar, thoracic and cervical myelography, CT cisternography after subarachnoid administration; arthrography, endoscopic retrograde pancreato (ERPT), endoscopic retrograde cholangiopancreatography (ERCP), salpingography, sialography and studies of the gastrointestinal tract.

Pregnancy and lactation:
Omnipak should not be used in pregnant women except in cases where the benefit of its use outweighs the risk of such a study and a physician appointed by necessity.
Contrast agents to a small extent excreted into breast milk and minimally absorbed deca durabolin dosage in the intestine. Therefore, the probability of harm to the baby through breast-feeding is unlikely. Nevertheless, it is advisable to refrain from breastfeeding for 24 hours after administration of Omnipaque.